Gilead Improves Drug Safety and Supports AI Roadmap with TIBCO Spotfire Enhanced data exploration with real-time analytics CHALLENGE Digital transformation is a continuous process for Gilead, because in its FDA regulated industry, pharmacological research, development, and manufacturing are continuously changing. Life Sciences is evolving, with companies investigating drug side effects and safety more thoroughly. To keep up, Gilead needed an analytics platform that would allow deeper data discovery and intuitive data visualizations. “Our requirement was interactive visualizations that could support exploratory data analysis for a highly regulated environment, and yet meet our futuristic AI pathway and help us embrace open source,” said Vishakha Mujoo, manager of R&D information

Join for free to read